FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Hydrocortisone Sodium Succinate Injection
Status: Resolved
»Duration of Shortage: 03/24/2023 - 02/24/2026
»Therapeutic Categories: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Pulmonary/Allergy; Renal; Rheumatology

Expand all

Cipla Limited (Revised 02/24/2026)

Company Contact Information:
844-247-5287

Presentation

• Hydrocortisone Sodium Succinate, Injection, 100 mg/ Vial (NDC 69097-004-67)

Note:

• Available

Hospira, Inc., a Pfizer Company (Revised 02/24/2026)

Company Contact Information:
844-646-4398

Presentation

• Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)
• Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)
• Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)
• Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)
• Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)
• Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)
• Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)

Note:

• Available